Cargando…
S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY
Autores principales: | Roddie, Claire, Sandhu, Karamjeet, Tholouli, Eleni, Shaughnessy, Paul, Barba Suñol, Pere, Nuno Direito de Morais Guerreiro, Manuel, Abedi, Mehrdad, Bishop, Michael, Yared, Jean, Ghobadi, Armin, Yallop, Deborah, Logan, Aaron, Amer, Beitinjaneh, Pantin, Jeremy, Arellano, Martha L, Chaganti, Sridhar, Malladi, Ram, Menne, Tobias, Escamilla, Virginia, Hodby, Katharine, Gundabolu, Krishna, Mountjoy, Luke, Odwyer, Kristen, Abedin, Sameem, Alkhateeb, Hassan, Shah, Bijal, Basilico, Silvia, Cluxton, Deborah, Dawes, Joanna, Lao-Sirieix, Pierre, Raymond, Meera, Shang, Justin, Hu, Yanqing, Pittari, Gianfranco, Saxena, Kapil, Brugger, Wolfram, Zhang, Y, Pule, Martin, Park, Daniel, De Angelo, Daniel, Jabbour, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428320/ http://dx.doi.org/10.1097/01.HS9.0000967960.99850.6d |
Ejemplares similares
-
Edward Samuel Broadway OBE
Publicado: (2021) -
Expert view: Susie Sanderson OBE
por: Sanderson OBE, Susie
Publicado: (2021) -
Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma
por: Aydilek, Enver, et al.
Publicado: (2023) -
P1155: BREXUCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ROUTINE PRACTICE: UPDATED REPORT FROM THE US LYMPHOMA CAR T CONSORTIUM
por: Wang, Y., et al.
Publicado: (2022) -
Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma
por: Nishihori, Taiga, et al.
Publicado: (2022)